Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 98.58% is 17% above its 5-year average of 84.62%, around the middle of its 5-year range (20.08%–143.56%).
2.76% below its 12-month average of 101.38%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 94.95%.
GROSS MARGIN
98.58%
GROSS MARGIN AVG TTM
101.38%
GROSS MARGIN AVG 3Y
93.08%
GROSS MARGIN AVG 5Y
84.62%
GROSS MARGIN AVG 10Y
89.88%
GROSS MARGIN AVG 15Y
89.48%
GROSS MARGIN AVG 20Y
91.13%
CURRENT VS TTM AVG
-2.76%
CURRENT VS 3Y AVG
+5.91%
CURRENT VS 5Y AVG
+16.50%
CURRENT VS 10Y AVG
+9.68%
CURRENT VS 15Y AVG
+10.17%
CURRENT VS 20Y AVG
+8.18%
SECTOR MEDIAN · HEALTHCARE
40.82%
median of 781 covered companies
CURRENT VS SECTOR MEDIAN
+141.50%
vs the sector median at left
Ligand Pharmaceuticals Incorporated
Market Cap
$5.94B
Gross Margin
98.58%
TTM Avg
101.38%
3Y Avg
93.08%
5Y Avg
84.62%
Market Cap
$5.91B
Gross Margin
97.23%
TTM Avg
60.83%
3Y Avg
-170.72%
5Y Avg
-113.81%
Market Cap
$5.76B
Gross Margin
54.49%
TTM Avg
70.12%
3Y Avg
77.23%
5Y Avg
64.22%
Market Cap
$5.67B
Gross Margin
-15.02%
TTM Avg
-3561.64%
3Y Avg
-7339.64%
5Y Avg
-5851.73%
Market Cap
$6.25B
Gross Margin
89.00%
TTM Avg
89.73%
3Y Avg
89.61%
5Y Avg
73.24%
Market Cap
$5.52B
Gross Margin
53.85%
TTM Avg
55.16%
3Y Avg
56.69%
5Y Avg
56.69%
Market Cap
$6.49B
Gross Margin
39.32%
TTM Avg
37.08%
3Y Avg
36.51%
5Y Avg
35.71%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated (LGND) | $5.94B | 98.58% | 101.38% | 93.08% | 84.62% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.91B | 97.23% | 60.83% | -170.72% | -113.81% |
| GRAIL Inc. (GRAL)vs › | $6.02B | -42.52% | -52.32% | -104.24% | -183.56% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.76B | 54.49% | 70.12% | 77.23% | 64.22% |
| CG Oncology Inc. (CGON)vs › | $5.67B | -15.02% | -3561.64% | -7339.64% | -5851.73% |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.25B | 89.00% | 89.73% | 89.61% | 73.24% |
| RadNet, Inc. (RDNT)vs › | $5.53B | 9.70% | 9.04% | 10.84% | 11.30% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | 53.85% | 55.16% | 56.69% | 56.69% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.49B | 39.32% | 37.08% | 36.51% | 35.71% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.50B | 60.14% | 62.77% | 60.62% | 54.58% |
Gross Margin
98.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 94.95% |
| 2026-03-31 | 95.99% |
| 2025-12-31 | 143.56% |
| 2025-09-30 | 78.50% |
| 2025-06-30 | 93.90% |
| 2025-03-31 | 89.30% |
| 2024-12-31 | 93.37% |
| 2024-09-30 | 75.88% |
| 2024-06-30 | 136.90% |
| 2024-03-31 | 64.27% |
| 2023-12-31 | 94.08% |
| 2023-09-30 | 89.40% |
| 2023-06-30 | 93.67% |
| 2023-03-31 | 91.55% |
| 2022-12-31 | 20.08% |
| 2022-09-30 | 76.10% |
| 2022-06-30 | 75.34% |
| 2022-03-31 | 87.13% |
| 2021-12-31 | 83.46% |
| 2021-09-30 | 82.35% |
| 2021-06-30 | 63.87% |
| 2021-03-31 | 85.22% |
| 2020-12-31 | 83.23% |
| 2020-09-30 | 84.82% |
| 2020-06-30 | 81.55% |
| 2020-03-31 | 85.88% |
| 2019-12-31 | 92.83% |
| 2019-09-30 | 87.31% |
| 2019-06-30 | 90.37% |
| 2019-03-31 | 91.13% |
| 2018-12-31 | 95.04% |
| 2018-09-30 | 96.80% |
| 2018-06-30 | 98.74% |
| 2018-03-31 | 98.60% |
| 2017-12-31 | 96.56% |
| 2017-09-30 | 92.85% |
| 2017-06-30 | 96.77% |
| 2017-03-31 | 98.83% |
| 2016-12-31 | 92.42% |
| 2016-09-30 | 95.38% |
| 2016-06-30 | 96.31% |
| 2016-03-31 | 96.78% |
| 2015-12-31 | 95.83% |
| 2015-09-30 | 92.94% |
| 2015-06-30 | 85.88% |
| 2015-03-31 | 92.64% |
| 2014-12-31 | 82.60% |
| 2014-09-30 | 90.01% |
| 2014-06-30 | 88.82% |
| 2014-03-31 | 84.64% |
| 2013-12-31 | 91.06% |
| 2013-09-30 | 80.48% |
| 2013-06-30 | 87.33% |
| 2013-03-31 | 94.31% |
| 2012-12-31 | 82.93% |
| 2012-09-30 | 89.29% |
| 2012-06-30 | 92.42% |
| 2012-03-31 | 97.25% |
| 2011-12-31 | 84.09% |
| 2011-09-30 | 87.75% |
| 2011-06-30 | 78.25% |
| 2011-03-31 | 86.52% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 209.00% |
| 2009-09-30 | -92.82% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 82.79% |
| 2006-09-30 | 84.20% |
| 2006-06-30 | 78.81% |
| 2006-03-31 | 80.89% |
| 2005-12-31 | 83.07% |
| 2005-09-30 | 76.97% |
| 2005-06-30 | 76.71% |
| 2005-03-31 | 70.08% |
| 2004-12-31 | 72.81% |
| 2004-09-30 | 77.75% |
| 2004-06-30 | 75.47% |
| 2004-03-31 | 75.90% |
| 2003-12-31 | 84.96% |
| 2003-09-30 | 72.62% |
| 2003-06-30 | 73.34% |
| 2003-03-31 | 71.37% |
| 2002-12-31 | 79.80% |
| 2002-09-30 | 77.65% |
